Announcements
Investor News
BioPorto A/S
BioPorto Interim Result for the Second Quarter of 2025 - Continued progress with full execution of strategic objectives and strong NGAL sales growth.
Fri, 15 Aug 2025 05:57 GMT
BioPorto A/S
BioPortos delårsresultat for andet kvartal 2025 - Fortsat fremdrift med fuld eksekvering af strategiske mål og stærk NGAL-salgsvækst
Fri, 15 Aug 2025 05:57 GMT
BioPorto A/S
BioPorto A/S to host an investor webcast on the results for the first half of 2025
Tue, 29 Jul 2025 13:28 GMT
BioPorto A/S
BioPorto A/S afholder webcast for investorer om resultatet for første halvår 2025
Tue, 29 Jul 2025 13:28 GMT
BioPorto A/S
BioPorto attends the Association for Diagnostics & Laboratory Medicine meeting, where NGAL and Acute Kidney Injury will be a key focus among participants.
Mon, 28 Jul 2025 14:52 GMT